STANFORD UNIVERSITY
High-resolution tracking of T cell differentiation to predict and control alloreactive disease
High-resolution tracking of T cell differentiation to predict and control alloreactive disease is a funding opportunity from STANFORD UNIVERSITY, up to 131211, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative therapy for many malignant and non-malignant diseases. Despite advances in allo-HSCT, graft-versus-host disease (GVHD) remains a significant cause of morbidity and mortality in patients. GVHD is marked by the activation of donor…